Validation of Medication Non-adherence Model (UK)

Research has shown that nearly 50% of patients with chronic conditions around the globe do not adhere to their prescribed medicine, leading to enormous cost to the healthcare providers. Non-adherence can be due to various forms and have multiple causes.

To address this need, Philips Research has developed Medication Non-adherence model. This tool will help in developing a systemic way of assessing medication non-adherence and providing decision support for targeted intervention to healthcare professionals. The aim of this study is to validate this model with 750 chronically ill patients in UK.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Chronic Disease Chronic Illness Chronic Obstructive Pulmonary Disease Disease Attributes Endocrine System Diseases Glucose Metabolism Disorders Lung Diseases Lung Diseases, Obstructive Medication Management at Home Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Primary Care Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

18 year–89 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Swan Lane Medical Centre, Bolton, Greater Manchester, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with chronic disease between 18 -89 years old.
Chronic medication use (> 3 medications; excluding analgesic, ointment and eye drop medication)
Patients registered with a given Pharmacy at least 1 year before entering into the study.

Exclusion criteria

Patients who are illiterate in English.
Patients who are unable to give consent to the study.
Enrolled in another clinical trial, which requires change in their routinely medication.
Patients currently using automatic medication reminder services (excluding the pharmacy service).
Patients with dementia or any other mental conditions, that might affects the accuracy of the answers provided.

Treatment and study plan

Primary outcomes

Adherence determinants

Time frame: 6 months

Self-reported behavioral questionnaire completed at 3 monthly intervals

Secondary outcomes

Medication usage

Time frame: 18 months

Collecting refill data from the pharmacy where patients are registered to. Time Frame: 18 months (12 month prior to enrollment + 6 months during the study

Other outcomes

Adverse Events

Time frame: 18 months

Any adverse events (eg: hospitalisation, elective surgeries), which may have resulted change in their daily medication routine Time Frame: 18 months, meaning 12 month prior to enrollment + 6 months during the study

Sponsors and collaborators

Lead sponsor

Philips Healthcare

Industry

Registry information

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Apr 16, 2014
Registry last updated: Sep 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed